UnitedHealth Group (NYSE:UNH) Price Target Raised to $660.00 at Truist Financial

UnitedHealth Group (NYSE:UNH) had its price target raised by Truist Financial from $610.00 to $660.00 in a research report released on Friday,Benzinga reports. They currently have a buy rating on the healthcare conglomerate’s stock.

A number of other research analysts have also recently commented on the stock. KeyCorp restated an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Mizuho lifted their price objective on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a research report on Wednesday. Barclays lowered their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Piper Sandler reduced their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Twenty-one equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $632.85.

UnitedHealth Group Trading Up 0.8 %

NYSE UNH opened at $599.10 on Friday. UnitedHealth Group has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a market cap of $548.00 billion, a P/E ratio of 38.65, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The stock has a 50 day simple moving average of $512.87 and a two-hundred day simple moving average of $542.03. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period last year, the business posted $5.83 EPS. On average, analysts forecast that UnitedHealth Group will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.40%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by company insiders.

Institutional Trading of UnitedHealth Group

Several institutional investors and hedge funds have recently bought and sold shares of UNH. NewSquare Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group during the 4th quarter worth about $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group during the fourth quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Finally, AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $30,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.